VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CMECME Group Inc.
$221.00$80.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCMEQuarterly Financials

CME Group Inc. (CME) Quarterly Financials

120+ quarters historyFree accessUpdated daily

CME Group Inc. (CME) quarterly income statement — complete revenue, gross profit & net income history

CME Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue------------
Revenue Growth %------------
Cost of Goods Sold------------
COGS % of Revenue------------
Gross Profit1.66B1.41B1.3B1.47B1.44B1.3B1.37B1.33B1.28B1.23B1.13B1.15B
Gross Margin %88.14%85.38%84.55%86.9%87.41%85.52%86.19%86.64%86.16%85.21%84.64%84.88%
Gross Profit Growth %15.43%7.9%-4.8%10.74%11.99%6.37%20.6%15.01%3.62%20.85%9.06%9.75%
Operating Expenses347.4M388M327.4M341.1M327.6M357.4M341.4M327.2M322.3M363.2M312.1M315.9M
OpEx % of Revenue18.48%23.53%21.29%20.16%19.95%23.43%21.55%21.35%21.66%25.23%23.33%23.22%
Selling, General & Admin28.2M47.9M36.7M37.4M28.5M33.9M31M34.7M33.1M36.1M32.2M37.8M
SG&A % of Revenue1.5%2.91%2.39%2.21%1.74%2.22%1.96%2.26%2.22%2.51%2.41%2.78%
Research & Development------------
R&D % of Revenue------------
Other Operating Expenses------------
Operating Income1.31B1.02B972.6M1.13B1.11B947.1M1.02B1B959.6M863.2M820.2M838.6M
Operating Margin %69.66%61.84%63.25%66.74%67.47%62.09%64.64%65.29%64.49%59.97%61.31%61.65%
Operating Income Growth %18.2%7.65%-5.04%12.86%15.46%9.72%24.87%19.32%5.02%29.16%11.02%11.86%
EBITDA1.34B1.05B1.06B1.21B1.19B1.03B1.11B1.08B1.04B949.5M908.5M927.9M
EBITDA Margin %71.11%63.45%68.63%71.67%72.49%67.56%69.94%70.79%70.23%65.97%67.91%68.22%
EBITDA Growth %12.3%1.51%-4.77%11.79%13.93%8.53%21.97%16.91%4.24%25.12%9.62%10.49%
D&A (Non-Cash Add-back)27.2M26.5M82.6M83.4M82.5M83.4M83.9M84.2M85.3M86.3M88.3M89.3M
EBIT1.31B1.56B1.22B1.37B1.29B1.14B1.22B1.19B1.15B1.05B1.01B1.06B
Net Interest Income-43.6M1.78B-44M-44M-41.7M-40.7M-40.2M-40.1M-39.9M-39.7M-39.6M-40.2M
Interest Income01.78B0000000000
Interest Expense43.6M044M44M41.7M40.7M40.2M40.1M39.9M39.7M39.6M40.2M
Other Income/Expense------------
Pretax Income1.51B1.58B1.18B1.33B1.24B1.1B1.18B1.15B1.11B1.01B974.3M1.02B
Pretax Margin %80.36%95.74%76.55%78.62%75.8%71.89%74.28%75.33%74.83%69.9%72.83%74.72%
Income Tax356.6M410.4M269M305.2M288.6M222M264.1M271.3M258.2M191.4M224.1M238.8M
Effective Tax Rate %23.6%26%22.85%22.94%23.18%20.24%22.44%23.5%23.19%19.03%23%23.49%
Net Income1.15B1.17B908M1.01B956.2M874.6M912.8M883.2M855.2M814.6M750.2M777.6M
Net Margin %61.4%70.84%59.05%59.82%58.22%57.34%57.61%57.63%57.48%56.6%56.08%57.17%
Net Income Growth %20.72%33.55%-0.53%14.61%11.81%7.37%21.67%13.58%-3.24%27.7%10.39%17.37%
Net Income (Continuing)1.15B1.17B908M1.03B956.2M874.6M912.8M883.2M855.2M814.6M750.2M777.6M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)3.183.242.492.812.622.402.502.422.352.242.062.14
EPS Growth %21.37%35%-0.4%16.12%11.49%7.14%21.36%13.08%-3.29%28%8.99%17.58%
EPS (Basic)3.253.252.492.812.632.402.512.432.352.242.062.14
Diluted Shares Outstanding363.21M360.23M360.33M360.3M360.23M360.05M359.99M359.87M359.83M359.69M359.62M359.43M
Basic Shares Outstanding359.32M359.63M359.65M359.64M359.61M359.39M359.4M359.33M359.26M359.2M359.02M358.94M
Dividend Payout Ratio-38.96%50.14%44.98%268.5%47.88%45.85%47.38%272.26%49.12%53.32%51.41%